AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.
Open | $3.720 |
Close | $3.850 |
Volume / Avg. | 1.984M / 1.385M |
Day Range | 3.700 - 3.885 |
52 Wk Range | 3.580 - 8.050 |
Market Cap | $1.129B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 10.3% |
Days to Cover | 18.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AbCellera Biologics (NASDAQ: ABCL) through any online brokerage.
Other companies in AbCellera Biologics’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
The latest price target for AbCellera Biologics (NASDAQ: ABCL) was reported by Keybanc on Wednesday, May 8, 2024. The analyst firm set a price target for 7.00 expecting ABCL to rise to within 12 months (a possible 82.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for AbCellera Biologics (NASDAQ: ABCL) is $3.84 last updated Today at May 21, 2024 at 5:44 PM EDT.
There are no upcoming dividends for AbCellera Biologics.
AbCellera Biologics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for AbCellera Biologics.
AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.